Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs.

Objective: To evaluate how Amyotrophic Lateral Sclerosis (ALS) patients’ mortality rates change, based on different levels of forced vital capacity (FVC) and disease duration, providing a scheme of...